TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
In a first-person report published by Being Patient, Ron Carr describes three health notifications that changed how he viewed Alzheimer’s risk: an APOE4 result, a coronary artery calcium scan and a later notification whose details are not included in the supplied text. His account illustrates how risk information can prompt medical conversations, but it does not establish that testing or lifestyle changes prevent Alzheimer’s disease.
Patient advocate Ron Carr said an APOE4 genetic test and a coronary artery calcium scan changed how he understood his health risks, in a first-person report published October 6 by Being Patient. His account connects Alzheimer’s risk information with cardiovascular findings, but the supplied report excerpt ends before it explains the third notification named in the headline.
Carr wrote that a genetic test two years earlier found he carried two copies of APOE4, a gene variant associated with increased risk of late-onset Alzheimer’s disease, though other genes may protect against APOE4 risk. He described initially treating the result as if it predicted his future, scrutinizing ordinary lapses in memory and changing his diet, exercise and supplement routines. He later emphasized that a risk factor is not a diagnosis.
Carr said a clinician at the University of Southern California’s Center for Personalized Brain Health discussed the relationship between APOE4 and lipid transport, a topic also relevant to molecules that may affect Alzheimer’s risk. He then had a coronary artery calcium scan. According to his account, it showed significant calcified plaque, concentrated largely in the left anterior descending coronary artery. Carr wrote that his clinicians diagnosed atherosclerotic cardiovascular disease and lowered his LDL cholesterol and ApoB targets, with medication and dietary changes.
He said follow-up testing found no evidence of structural heart damage. The article presents these events as Carr’s personal experience, not as evidence that an APOE4 result predicts an individual’s outcome or that a particular diet or treatment prevents dementia. The supplied text stops during his discussion of how the scan changed conversations with people close to him.
How Risk Information Changed Carr’s Care
Carr’s account shows how a genetic result can prompt someone to seek more information, while also describing the anxiety that can follow when a risk marker feels like a diagnosis. His later shift in perspective is central to the report: APOE4 indicates elevated risk, not certainty, and the result alone cannot establish whether a person will develop Alzheimer’s disease.
The heart scan also gave Carr information about a separate health condition that, as he describes it, was not apparent from how he felt. His experience may help readers understand why he pursued clinical assessment, but one person’s story cannot show how common such findings are or what screening is appropriate for others. Decisions about genetic testing, imaging and treatment depend on individual circumstances and clinician guidance.
As an affiliate, we earn on qualifying purchases.
From APOE4 Result to Heart Scan
Carr is described by Being Patient as a retired local government executive and patient advocate focused on Alzheimer’s prevention, genetic testing and cardiovascular health. In the report, he recounts that his father had a heart attack at age 65. Carr said he had run regularly, followed a heart-conscious diet and eventually accepted statin therapy before the scan revealed coronary plaque.
He also cites the Lancet Commission’s estimate that up to 45% of dementia cases may be attributable to potentially modifiable risk factors. That is a population-level estimate presented in Carr’s article; it does not mean that an individual can prevent dementia or determine their personal risk by changing specific habits. The excerpt provides no further detail about the commission’s methods or the report’s third notification.
“APOE4 is not a diagnosis. It is a risk factor.”
— Ron Carr, in Being Patient
As an affiliate, we earn on qualifying purchases.
The Third Notification Is Missing
The supplied source material does not include the full article. It cuts off during Carr’s account after the heart scan, so the identity and significance of the third notification are unknown. It is also unclear what subsequent conversations or health changes the complete report describes.
The excerpt does not provide the scan’s numerical calcium score, the specific medications or doses used, or details of the follow-up tests. It does not establish whether Carr’s experience is representative, nor does it supply evidence that the testing or changes he describes reduced his risk of Alzheimer’s disease.
As an affiliate, we earn on qualifying purchases.
Full Report Needed for the Final Alert
The next step for readers seeking the complete account is to consult the full Being Patient report, which may explain Carr’s third notification and how it affected his decisions. Based on the supplied excerpt, no additional test result, treatment outcome or future milestone can be confirmed.
Carr’s published account supports a limited takeaway: he says the genetic result led him to learn more about risk, and the scan revealed coronary plaque that prompted further care. Readers considering genetic testing, heart imaging or changes to medication should discuss their own situation with a qualified health professional rather than treating his experience as a personal care plan.
blood test for cardiovascular health
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did Carr learn from his genetic test?
He wrote that the test found two copies of APOE4, a genetic risk factor associated with late-onset Alzheimer’s disease. He stressed that it was not a diagnosis.
What did the coronary scan show?
Carr said his coronary artery calcium scan showed significant calcified plaque, largely in the left anterior descending artery. He wrote that clinicians diagnosed atherosclerotic cardiovascular disease; the excerpt gives no numerical scan score.
What was the third health notification?
The supplied excerpt does not say. It ends during Carr’s discussion of the heart scan, before the article’s third notification is described.
Does APOE4 mean someone will develop Alzheimer’s?
No. In Carr’s account, APOE4 is described as a risk factor, not a diagnosis. The excerpt does not provide an individual prediction or establish that any particular intervention prevents the disease.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
